Doctors at telehealth corporates have moved to Wegovy and Mounjaro as weight loss treatments ahead of today’s ban on semaglutide compounding. The Federal Government announced…
Novo Nordisk’s subcutaneous weight-loss drug Wegovy will hit Australian shelves this month, two years after it received TGA approval. The once-weekly injectable semaglutide formulation will…
More than a year before the Federal Government announced its compounding ban, the pharmaceutical giant Novo Nordisk was making complaints to AHPRA about pharmacies compounding…
The TGA is banning pharmacists from compounding semaglutide and other GLP-1 receptor agonists, starting 1 October. About 20,000 patients are currently using compounded semaglutide for…
Telehealth corporate Eucalyptus is making headlines for prescribing off-label compounded semaglutide as part of an online weight loss program that costs up to $599 a…
A doctor is warning GPs to be careful when prescribing compounded semaglutide, saying both she and her prescribing doctor appear to have been taken in…
Overall, 5.5% of adolescents use weight loss products, with higher use among girls, according to a systematic review and meta-analysis in JAMA Network Open. Deakin…
The social media frenzy around semaglutide may have contributed to dozens of overdoses, says a leading endocrinologist, with poisons information centres seeing a spike in…
Adding semaglutide to standard care cuts the risk of fatal and non-fatal cardiac events by 20% in adults with pre-existing cardiovascular disease but not diabetes,…
Semaglutide may be a new therapeutic option for obesity-related heart failure with preserved ejection fraction, with results from a landmark study showing substantial reductions in…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
